Available from: Dariush Mozaffarian 1, Monica Agarwal 2, Monica Aggarwal 3, Lydia Alexander 4, Caroline M Apovian 5, Shagun Bindlish 6, Jonathan Bonnet 7, W Scott Butsch 8, Sandra Christensen 9, Eugenia Gianos 10, Mahima Gulati 11, Alka Gupta 12 13, Debbie Horn 14, Ryan M Kane 15 16, Jasdeep Saluja 17, Deepa Sannidhi 18, Fatima Cody Stanford 19 20, Emily A Callahan 1
Mimic natural GLP-1 hormone better glucose control Slow gastric emptying increased satiety Promote significant weight loss Reduce cardiovascular risks in many patients Key insights: Once-weekly injections improve patient compliance Oral options like Rybelsus are expanding accessibility Dual agonists (like tirzepatide) are pushing outcomes even further But its not just about benefits: Common adverse effects include nausea, vomiting, and GI discomforthighlighting the importance of dose titration and patient monitoring
Best Practices for Handling Missed Doses : We will provide guidance on what to do if you miss a dose and how to safely resume your treatment
V.ChappleC.NovoselovS
